Skip to main content
Signal8

BIOTECH GROWTH N V

SEC insider (Form 3/4/5 filer). CIK 0001259869. 10% Owner at Black Diamond Therapeutics, Inc. (BDTX) and 1 other issuer. 11 reported Form 4/5 transactions since Sep 2024; latest on Mar 19, 2025. Located in CURACAO, P8.

Companies BIOTECH GROWTH N V has filed insider reports for

  • Black Diamond Therapeutics, Inc. (BDTX): 10% Owner
  • ESSA Pharma Inc. (EPIX): 10% Owner
BIOTECH GROWTH N V profile photo

BIOTECH GROWTH N V

CIK: 0001259869

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Black Diamond Therapeutics, Inc. logo
BDTX

Black Diamond Therapeutics, Inc.

10% Owner
ESSA Pharma Inc. logo
EPIX

ESSA Pharma Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (11 total)

  • Black Diamond Therapeutics, Inc. logo
    BDTX

    Black Diamond Therapeutics, Inc.

    Mar 19, 2025
    Sale
    Direct
    1M shares at avg. $2.07$2.1M
  • Black Diamond Therapeutics, Inc. logo
    BDTX

    Black Diamond Therapeutics, Inc.

    Mar 19, 2025
    Sale
    Direct
    300K shares at avg. $1.94$583K
  • Black Diamond Therapeutics, Inc. logo
    BDTX

    Black Diamond Therapeutics, Inc.

    Mar 19, 2025
    Sale
    Direct
    1M shares at avg. $2.31$2.3M
  • Black Diamond Therapeutics, Inc. logo
    BDTX

    Black Diamond Therapeutics, Inc.

    Mar 19, 2025
    Sale
    Direct
    2M shares at avg. $2.00$4.0M
  • Black Diamond Therapeutics, Inc. logo
    BDTX

    Black Diamond Therapeutics, Inc.

    Mar 19, 2025
    Sale
    Direct
    400K shares at avg. $2.09$837K
  • Black Diamond Therapeutics, Inc. logo
    BDTX

    Black Diamond Therapeutics, Inc.

    Mar 19, 2025
    Sale
    Direct
    584.3K shares at avg. $1.95$1.1M
  • Black Diamond Therapeutics, Inc. logo
    BDTX

    Black Diamond Therapeutics, Inc.

    Mar 19, 2025
    Sale
    Direct
    500K shares at avg. $2.12$1.1M
  • ESSA Pharma Inc. logo
    EPIX

    ESSA Pharma Inc.

    Nov 1, 2024
    Sale
    Direct
    2M shares at avg. $1.53$3.1M
  • ESSA Pharma Inc. logo
    EPIX

    ESSA Pharma Inc.

    Nov 1, 2024
    Sale
    Direct
    2M shares at avg. $1.53$3.1M
  • ESSA Pharma Inc. logo
    EPIX

    ESSA Pharma Inc.

    Nov 1, 2024
    Sale
    Direct
    2M shares at avg. $1.53$3.1M

1-10 of 11